Fly-In 2024

Because aging is the driver of chronic diseases, therapies that directly target aging physiology could prevent or cure multiple chronic age-related diseases. Researchers in the biology of aging are beginning to understand how the biological processes of aging promote disease, and dozens of biotechnology companies are applying that understanding to delay the onset and progression of age-associated health problems. Such interventions, generally termed “longevity medicine,” have the potential to dramatically decrease both mortality and healthcare costs, likely to a greater extent than even the complete cure of any one disease, while alleviating suffering and improving quality of life — revolutionizing healthcare for all Americans.

Recognizing that there is a need for federal investment and commercialization in the longevity medicine space, the Alliance for Longevity Initiatives is hosting our inaugural D.C. Fly-In, which will include the first ever Longevity Science Briefing on March 21st, 2024. Join us for an invigorating two-day event including an intimate Q&A session with ARPA-H, the first-ever Longevity Science Briefing and an exclusive dinner with a keynote speech by Former Speaker of the House Newt Gingrich. The first ever A4LI D.C. Fly-In will set the foundation for awareness and growth for this crucial area of longevity biotechnology research and we hope to see you all there!